I bought Gilead about a year ago...Did a leap for the Jan 21 $80. It looked OK/fair with their pipeline of drugs...Pre COVID-19. Think I bought in the mid $60s. I found it from Royce Value Trust (RVT) years ago. Royce seems to find these gems...Cheap. It wasn't making much money, but they saw the potential years ago. Took their profit, then moved on. I'll get a good profit, but could have done better. If the deal doesn't get done or Remdesivir becomes a disappointment, I'll still have my option money and can do another covered call. Yeah, boring but profitable.
What I saw in Gilead before a potential buyout and the pandemic. GILD is a bio company with profits!! It has bought other bio companies in the past year or so. It has a PE under 20!! How many bios with a pipeline have a PE under 20. As I write, it pays over a 3.5% dividend. There is a lot to like about this company. And for me, this is an ideal company to buy the stock and do a LEAP on (I have a lot of money on the sidelines). This is more of a boring stable play, rather than a rolling the dice...
https://www.fool.com/investing/2020...m_medium=feed&utm_campaign=article&yptr=yahoo What they said...My same thinking. Still a good covered call stock.